BICYCLIC TETRAHYDROPYRAZOLEPYRIDINES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION, METHOD OF PHOSPHODIESTERASE INHIBITION, METHOD OF PATIENT TREATMENT Russian patent published in 1999 - IPC

Abstract RU 2131876 C1

FIELD: organic chemistry, biochemistry, medicine, pharmacy. SUBSTANCE: invention relates to bicyclic tetrahydropyrazole- -pyridines of the formula (I) where R1 is C1-3-alkyl; X - oxygen atom or two hydrogen atoms; R2 is C1-4-alkyl, indalyl, C3-7-cycloalkyl or the group of the formula (II) ; a = 1 or 2; b and c = 0 or 1; R4 - H, C1-5-alkyl, alkoxyl, C3-6-cyclo- -alkoxyl, halogen atom, CF3, CO2R6, CONR6R7, NR6R7; R6, R7 - H or C1-4-alkyl; Z is SO; Y is C1-5-alkylene; R3 has values indicated for R2 and methylenecyclopropyl at condition that R2 and R3 can not mean simultaneously methyl, or their pharmaceutically acceptable salts and a pharmaceutical composition based on said that inhibit activity of phosphodiesterase of type-IV and production of tumor necrosis factor. EFFECT: enhanced effectiveness of compounds and composition as inhibitors of phosphodiesterase, improved method of treatment. 8 cl, 7 tbl, 39 ex

Similar patents RU2131876C1

Title Year Author Number
TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO-[3,4-C]-1,2,4-TRIAZOLO- -[4,3-A]-PYRIDINES, METHOD OF INHIBITION OF ACTIVITY OF PHOSPHODIESTERASE TYPE IV AND METHOD OF INHIBITION OF TUMOR-SPECIFIC NECROSIS FACTOR PRODUCING 1996
  • Allen Jakob Daplehntir
  • Kelvin Kuper
RU2161158C2
SUBSTITUTED PYRAZOLES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, USING PHARMACEUTICAL COMPOSITION AND METHOD FOR INHIBITION OF CATHEPSIN S ACTIVITY 2001
  • Batler Kristofer R.
  • Kaj Kh'Jui
  • Ehdvards Dzhejms P.
  • Grajs Cheril A.
  • Gastin Darin Dzh.
  • Kkhatuja Kharipada
  • Meduna Stiven P.
  • Pajo Barbara A.
  • Sekhon Klark A.
  • Tehjs Kevin L.
  • Vej Dzhianmej
RU2317988C2
PYRAZOLOPYRIMIDINES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS 1993
  • Jukhping Liang Chen
RU2124016C1
HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION AND METHOD OF INHIBITION OF 5-LIPOXYGENASE ACTIVITY 1995
  • Rodni V. Stivens
  • Takasi Mano
  • Kazunari Nakao
  • Josijuki Okumura
RU2136666C1
PRODRUGS OF CONJUGATED BICYCLIC C5aR ANTAGONISTS 2019
  • Fan, Pingchen
  • Lui, Rebecca M.
  • Singh, Rajinder
  • Mali, Venkat Reddy
  • Zeng, Yibin
  • Zhang, Penglie
RU2794327C2
DERIVATIVES OF ARYLSULFONYLAMINOHYDROXAMIC ACID, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION OF MATRIX METALLOPROTEINASES AND METHOD OF PATIENT TREATMENT 1996
  • Ral'F P.Robinson
  • Dzhejms P.Ritstsi
RU2145597C1
AMINOSUBSTITUTED PYRAZOLES AND INTERMEDIATE AMINO SUBSTITUTED PYRAZINES 1993
  • Dzhen Majkl Brajt
RU2142455C1
SUBSTITUTED PYRAZOLES 2001
  • Brajtenbukher Dzh. Gaj
  • Kaj Kh'Jui
  • Ehdvards Dzhejms P.
  • Grajs Cheril A.
  • Gastin Darin Dzh.
  • Kkhatuja Kharipada
  • Meduna Stiven P.
  • Pajo Barbara A.
  • Tehjs Kevin L.
  • Vej Dzhianmej
RU2286343C2
SUBSTITUTED PYRAZOLES, PHARMACEUTICAL COMPOSITION BASED ON SAID, METHOD OF PATIENT TREATMENT, INTERMEDIATE COMPOUND 1993
  • Dzhen M.Brajt
  • Uillard M.Uehlch
RU2130453C1
METHOD FOR TREATMENT OF ALLERGY BY USING SUBSTITUTED PYRAZOLES 2001
  • Batler Kristofer R.
  • Kaj Kh'Jui
  • Ehdvards Dzhejms P.
  • Grajs Cheril A.
  • Gu Jin
  • Gastin Darin Dzh.
  • Karlsson Lars
  • Kkhatuja Kharipada
  • Meduna Stiven P.
  • Pajo Barbara A.
  • Sekhon Klark A.
  • Sun Sikvan
  • Tehjs Kevin L.
  • Termond Robin L.
  • Vej Dzhianmej
RU2290179C2

RU 2 131 876 C1

Authors

Allen Dzhekob Djuplant'E

Dates

1999-06-20Published

1994-06-16Filed